Optomed Oyj (HEL:OPTOMED)
1.582
+0.032 (2.06%)
Jul 28, 2026, 5:46 PM EET
Optomed Oyj Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -6.16 | -6.64 | -5.45 | -4.44 | -5.47 | -4.25 |
Depreciation & Amortization | 2.58 | 2.52 | 2.5 | 2.19 | 3.15 | 2.69 |
Other Adjustments | 0.42 | 0.97 | 0.19 | 0.76 | -0.15 | -0.02 |
Change in Receivables | -0.42 | -0.48 | -0.34 | 1.09 | 0.2 | -1.41 |
Changes in Inventories | -1.11 | -0.49 | 0.9 | 0.12 | -0.07 | -0.34 |
Changes in Accounts Payable | 0.49 | 1.7 | 0.69 | -0.08 | 0.17 | 0.52 |
Changes in Other Operating Activities | -0.04 | -0.05 | -0.09 | -0.26 | -0.2 | -0.13 |
Operating Cash Flow | -4.25 | -2.48 | -1.6 | -0.62 | -2.37 | -2.94 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.49 | -0.56 | -0.28 | -0.21 | -0.78 | -0.46 |
Purchases of Intangible Assets | -1.59 | -1.8 | -1.84 | -2.2 | -2.25 | -2.11 |
Investing Cash Flow | -2.07 | -2.36 | -2.12 | -2.41 | -3.03 | -2.57 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | - | - | 1.37 |
Long-Term Debt Repaid | -1.27 | -1.38 | -1.55 | -2.38 | -1.33 | -0.74 |
Net Long-Term Debt Issued (Repaid) | -1.27 | -1.38 | -1.55 | -2.38 | -1.33 | 0.63 |
Issuance of Common Stock | 5.98 | 5.98 | 9.18 | 4.31 | 9.01 | 1.01 |
Net Common Stock Issued (Repurchased) | 5.98 | 5.98 | 9.18 | 4.31 | 9.01 | 1.01 |
Other Financing Activities | -0.42 | -0.42 | -0.55 | -0.32 | -0.68 | 0 |
Financing Cash Flow | 4.3 | 4.19 | 7.08 | 1.61 | 7 | 1.64 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.09 | 0.1 | -0.02 | 0.01 | 0.12 | 0.07 |
Net Cash Flow | -2.02 | -0.65 | 3.37 | -1.42 | 1.61 | -3.88 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4.74 | -3.04 | -1.87 | -0.83 | -3.15 | -3.4 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -28.83% | -17.80% | -12.44% | -5.48% | -21.49% | -22.91% |
Free Cash Flow Per Share | -0.24 | -0.15 | -0.10 | -0.05 | -0.22 | -0.25 |
Levered Free Cash Flow | -6 | -4.91 | -3.27 | -5.06 | -4.53 | -1.35 |
Unlevered Free Cash Flow | -4.57 | -2.86 | -2.16 | -2.14 | -2.75 | -2.42 |